CORPORATE ACTIONS

The shares of the company "LAVIPHARM S.A." (GRS246003008) are traded on the ATHEX ex-rights in terms of 10.01868413773180 new (CR) shares for every 1 old (CR) share held - with issue of 170,588,235 new CR shares - at an issue price of €0.34 per share. The rights' trading period is set from December 1, 2022, to December 9, 2022 (included). The rights' subscription period is set from December 1, 2022, to December 14, 2022 (included). It is clarified, according to article 2.6.3. of the ATHEX Rulebook and to decisions No 22 & 26 of the ATHEX BoD, as in effect, that the fluctuation price limits of the share price only for the trading session on November 28, 2022, are set as follows: +20% at the closing share price of the ATHEX last trading session (25/11/2022): €0.3680 and -20% at the adjusted start share price: €0.3420.